美国 · SEC FORM 4
Cytosorbents Corp
CTSO · Nasdaq · CIK 0001175151 · Healthcare · Medical Devices
内部人信号
4 位买方 · 10 条买入交易行 · $269.3K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Purchase size is modest relative to the model scale
- ⚠ 角色得分低 · 买入者中职位最高的是：Chief Executive Officer（CEO、董事长和持股 10% 以上的股东得分最低）
- ✓ Cluster breadth is broad · 4+ insiders
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Chief Executive Officer, Director, President and COO. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 69.2
- 69.0
- 68.9
- 68.8
- 68.5
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -40.5%
- 3M
- -50.1%
- 6M
- -68.9%
- 12M
- -80.6%
波动率与流动性
- 波动率
- 82.7%
- Beta
- —
- 平均每日成交额
- USD 46,743
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- -22.1%
- ROE
- -138.9%
- 细分行业
- Medical Devices
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 123,890
- 上期报告
- 120,606
- 日均成交量
- 10,339
- 回补天数
- 12.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Sobel Alan D. | 买入 (P) | Common Stock | 2,500 | USD 6.10 | USD 15,254 | SEC 申报 ↗ |
| 2026-09-15 | Chan Phillip P. | 买入 (P) | Common Stock | 3,774 | USD 6.00 | USD 22,644 | SEC 申报 ↗ |
| 2026-09-14 | Capponi Vincent | 买入 (P) | Common Stock | 2,073 | USD 6.05 | USD 12,537 | SEC 申报 ↗ |
| 2026-09-04 | Chan Phillip P. | 买入 (P) | Common Stock | 200,000 | USD 0.35 | USD 70,000 | SEC 申报 ↗ |
| 2026-06-15 | MARIANI PETER J | 买入 (P) | Common Stock | 100,000 | USD 0.44 | USD 44,000 | SEC 申报 ↗ |
| 2026-06-15 | Chan Phillip P. | 买入 (P) | Common Stock | 10,333 | USD 0.43 | USD 4,443 | SEC 申报 ↗ |
| 2026-06-12 | Chan Phillip P. | 买入 (P) | Common Stock | 251,136 | USD 0.40 | USD 100,454 | SEC 申报 ↗ |
| 2024-12-13 | MARIANI PETER J | 买入 (P) | Common Stock | 20,000 | USD 0.96 | USD 19,200 | SEC 申报 ↗ |
| 2024-12-12 | MARIANI PETER J | 买入 (P) | Common Stock | 20,000 | USD 0.89 | USD 17,800 | SEC 申报 ↗ |
| 2024-12-11 | MARIANI PETER J | 买入 (P) | Common Stock | 11,363 | USD 0.89 | USD 10,113 | SEC 申报 ↗ |
| 2023-12-13 | Sobel Alan D. | 买入 (P) | Common Stock | 22,557 | USD 1.33 | USD 30,001 | SEC 申报 ↗ |
| 2023-12-13 | Kim Jiny | 买入 (P) | Common Stock | 7,519 | USD 1.33 | USD 10,000 | SEC 申报 ↗ |
| 2023-12-13 | Jones Edward Raymond | 买入 (P) | Common Stock | 7,519 | USD 1.33 | USD 10,000 | SEC 申报 ↗ |
| 2023-12-13 | Deliargyris Efthymios | 买入 (P) | Common Stock | 22,557 | USD 1.33 | USD 30,001 | SEC 申报 ↗ |
| 2023-12-13 | Chan Phillip P. | 买入 (P) | Common Stock | 75,188 | USD 1.33 | USD 100,000 | SEC 申报 ↗ |
Form 4 申报证据
11 transaction lines in the latest 365-day window; 116 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Sobel Alan D. | 买入 (P) | Common Stock | 2,500 | USD 6.10 | USD 15,254 | SEC 申报 ↗ |
| 2026-09-15 | Chan Phillip P. | 买入 (P) | Common Stock | 3,774 | USD 6.00 | USD 22,644 | SEC 申报 ↗ |
| 2026-09-14 | Capponi Vincent | 买入 (P) | Common Stock | 2,073 | USD 6.05 | USD 12,537 | SEC 申报 ↗ |
展开近期 Form 4 证据 (8 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Sobel Alan D. | 买入 (P) | Common Stock | 2,500 | USD 6.10 | USD 15,254 | SEC 申报 ↗ |
| 2026-09-15 | Chan Phillip P. | 买入 (P) | Common Stock | 3,774 | USD 6.00 | USD 22,644 | SEC 申报 ↗ |
| 2026-09-14 | Capponi Vincent | 买入 (P) | Common Stock | 2,073 | USD 6.05 | USD 12,537 | SEC 申报 ↗ |
| 2026-09-04 | Chan Phillip P. | 买入 (P) | Common Stock | 200,000 | USD 0.35 | USD 70,000 | SEC 申报 ↗ |
| 2026-06-15 | MARIANI PETER J | 买入 (P) | Common Stock | 100,000 | USD 0.44 | USD 44,000 | SEC 申报 ↗ |
| 2026-06-15 | Chan Phillip P. | 买入 (P) | Common Stock | 10,333 | USD 0.43 | USD 4,443 | SEC 申报 ↗ |
| 2026-06-12 | Chan Phillip P. | 买入 (P) | Common Stock | 251,136 | USD 0.40 | USD 100,454 | SEC 申报 ↗ |
| 2025-11-18 | Chan Phillip P. | 奖励／授予 (A) | Common Stock | 100,000 | USD 0.64 | USD 64,000 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CTSO |
| CIK | 0001175151 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 116 transaction lines from 2020-02-28 to 2026-09-15 54 P purchase lines · 4 S sale lines · 58 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.